Study on the financial performance of companies operating in the pharmaceutical industry in romania
The study aims at determining the financial performance of companies in the pharmaceutical industry between 2009 and 2014 by means of the indicator of the financial return rate, using multiple linear regressions as research method. By analysing the evolution of the share of companies in the pharmace...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Vasile Goldis University Press
2016-03-01
|
Series: | Studia Universitatis Vasile Goldis Arad, Seria Stiinte Economice |
Subjects: | |
Online Access: | https://doi.org/10.1515/sues-2016-0005 |
id |
doaj-d17a526dc81943d99ff61ac0ef458336 |
---|---|
record_format |
Article |
spelling |
doaj-d17a526dc81943d99ff61ac0ef4583362021-09-05T14:00:49ZengVasile Goldis University PressStudia Universitatis Vasile Goldis Arad, Seria Stiinte Economice1584-23392016-03-01261586810.1515/sues-2016-0005sues-2016-0005Study on the financial performance of companies operating in the pharmaceutical industry in romaniaBaltes Nicolae0Minculete (Piko) Georgiana Daniela1„Lucian Blaga” University of Sibiu„Lucian Blaga” University of SibiuThe study aims at determining the financial performance of companies in the pharmaceutical industry between 2009 and 2014 by means of the indicator of the financial return rate, using multiple linear regressions as research method. By analysing the evolution of the share of companies in the pharmaceutical industry based on the trend of the financial rate of return, we can estimate that the number of entities that resort to supporting the financial activities from loans and liabilities is growing in the period under analysis. This is due mainly to the liquidity crisis faced by entities, as a result of the high recovery duration of debts. Also, using the multiple linear regression we can highlight that, the financial return of pharmaceutical companies is positively influenced by their economic profitability, by the equity multiplier and by inflation, and negatively, by the net profit margin.https://doi.org/10.1515/sues-2016-0005financial performancefinancial returneconomic profitabilitythe method of multiple linear regressionequity multipliernet profit marging19g39 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Baltes Nicolae Minculete (Piko) Georgiana Daniela |
spellingShingle |
Baltes Nicolae Minculete (Piko) Georgiana Daniela Study on the financial performance of companies operating in the pharmaceutical industry in romania Studia Universitatis Vasile Goldis Arad, Seria Stiinte Economice financial performance financial return economic profitability the method of multiple linear regression equity multiplier net profit margin g19 g39 |
author_facet |
Baltes Nicolae Minculete (Piko) Georgiana Daniela |
author_sort |
Baltes Nicolae |
title |
Study on the financial performance of companies operating in the pharmaceutical industry in romania |
title_short |
Study on the financial performance of companies operating in the pharmaceutical industry in romania |
title_full |
Study on the financial performance of companies operating in the pharmaceutical industry in romania |
title_fullStr |
Study on the financial performance of companies operating in the pharmaceutical industry in romania |
title_full_unstemmed |
Study on the financial performance of companies operating in the pharmaceutical industry in romania |
title_sort |
study on the financial performance of companies operating in the pharmaceutical industry in romania |
publisher |
Vasile Goldis University Press |
series |
Studia Universitatis Vasile Goldis Arad, Seria Stiinte Economice |
issn |
1584-2339 |
publishDate |
2016-03-01 |
description |
The study aims at determining the financial performance of companies in the pharmaceutical industry between 2009 and 2014 by means of the indicator of the financial return rate, using multiple linear regressions as research method. By analysing the evolution of the share of companies in the pharmaceutical industry based on the trend of the financial rate of return, we can estimate that the number of entities that resort to supporting the financial activities from loans and liabilities is growing in the period under analysis. This is due mainly to the liquidity crisis faced by entities, as a result of the high recovery duration of debts. Also, using the multiple linear regression we can highlight that, the financial return of pharmaceutical companies is positively influenced by their economic profitability, by the equity multiplier and by inflation, and negatively, by the net profit margin. |
topic |
financial performance financial return economic profitability the method of multiple linear regression equity multiplier net profit margin g19 g39 |
url |
https://doi.org/10.1515/sues-2016-0005 |
work_keys_str_mv |
AT baltesnicolae studyonthefinancialperformanceofcompaniesoperatinginthepharmaceuticalindustryinromania AT minculetepikogeorgianadaniela studyonthefinancialperformanceofcompaniesoperatinginthepharmaceuticalindustryinromania |
_version_ |
1717811297798586368 |